In Vivo Cytoskeletal AMPA Receptor Transport Imaging in C. elegans
ABSTRACT Long‐distance intracellular transport of ionotropic glutamate receptors (iGluRs) is essential for proper excitatory synaptic function underlying learning and memory. Many neuropsychiatric and neurodegenerative conditions have abnormal iGluR transport and trafficking, leading to an intense interest in the mechanisms and factors regulating these
Michaelis A. K., Hoerndli F. J.
wiley +1 more source
Corrigendum to: Bacterial Group II Intron Genomic Neighborhoods Reflect Survival Strategies: Hiding and Hijacking. [PDF]
Waldern J +3 more
europepmc +1 more source
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee +5 more
wiley +1 more source
Splicing defective mutants of theCOXIgene of yeast mitochondrial DNA: initial definition of the maturase domain of the group II intron AI2 [PDF]
John V. Moran +6 more
openalex +1 more source
Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis
Cisplatin is a chemotherapy drug that causes permanent hearing loss by damaging a critical tissue lining the inner ear, called the stria vascularis (SV). Currently, the molecular mechanisms of SV damage are largely unknown and the incidence of ototoxicity in patients cannot be reliably predicted.
Tara Lazetic +4 more
wiley +1 more source
Cysteine Mutagenesis of a Group II Intron-Encoded Protein Supports Splicing, Mobility, and Site-Specific Labeling. [PDF]
Harper JA +3 more
europepmc +1 more source
In silico characterisation and chromosomal localisation of human RRH (peropsin) – implications for opsin evolution [PDF]
Bellingham, J, Foster, R G, Wells, D J
core +1 more source
PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou +14 more
wiley +1 more source
Structural basis for the evolution of a domesticated group II intron-like reverse transcriptase to function in host cell DNA repair. [PDF]
Park SK +6 more
europepmc +1 more source
Cation-induced kinetic heterogeneity of the intron–exon recognition in single group II introns [PDF]
Danny Kowerko +6 more
openalex +1 more source

